MedTrace Logo

Treatment of APAP Toxicity With IV and Oral NAC 2008-2011

NCT01465542 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2023-07-25

No results posted yet for this study

Summary

Retrospective chart review of patients who receive N-acetylcysteine for Acetaminophen(APAP) toxicity to assess length of oral vs. IV treatment and the effect of a Clinical Pharmacology and Toxicology division in the management of APAP ingestions.

Conditions

  • Acetaminophen Toxicity

Sponsors & Collaborators

  • Akron Children's Hospital

    lead OTHER

Principal Investigators

  • Martha Blackford, PharmD · CHMCA

Eligibility

Min Age
1 Month
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2011-08-31
Completion
2011-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01465542 on ClinicalTrials.gov